(Q39526933)

12 September 2017

1 reference

title

Evolution of high-dose cisplatin (English)

1 reference

12 September 2017

W M Holleran

1

1 reference

PubMed ID

3049431

12 September 2017

M W DeGregorio

series ordinal

2

1 reference

12 September 2017

1 June 1988

1 reference

Investigational New Drugs

12 September 2017

1 reference

12 September 2017

6

1 reference

12 September 2017

2

1 reference

12 September 2017

135-142

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00195372

12 September 2017

0 references

cites work

Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity

1 reference

12 December 2020

Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model

1 reference

12 December 2020

Clinical trials of cis-diamminedichloroplatinum (NSC-119875).

1 reference

12 December 2020

Clinical pharmacology of high-dose cisplatin

1 reference

12 December 2020

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer

1 reference

12 December 2020

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

1 reference

12 December 2020

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

1 reference

12 December 2020

Etoposide and very high dose cisplatin: salvage therapy for patients with advanced germ cell neoplasms

1 reference

12 December 2020

Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats

1 reference

12 December 2020

Kinetics of cis-dichlorodiammineplatinum

1 reference

12 December 2020

A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate

1 reference

12 December 2020

Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycin

1 reference

12 December 2020

Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration

1 reference

12 December 2020

High-dose cisplatin therapy for cancer of the ovary: neurotoxicity.

1 reference

12 December 2020

Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat

1 reference

12 December 2020

Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide

1 reference

12 December 2020

High-dose cisplatin in patients with advanced malignancies.

1 reference

12 December 2020

Dose-limiting myelosuppression associated with high-dose cisplatin (200 mg/m2) in hypertonic saline

1 reference

12 December 2020

Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model

1 reference

12 December 2020

Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis

1 reference

12 December 2020

High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity

1 reference

12 December 2020

High-Dose Cisplatin in Hypertonic Saline

1 reference

12 December 2020

A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique

1 reference

12 December 2020

High-dose cisplatin with sodium thiosulfate protection.

1 reference

12 December 2020

High-dose cisplatin in advanced head and neck cancer

1 reference

12 December 2020

Intraperitoneal cisplatin with systemic thiosulfate protection

1 reference

12 December 2020

High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors

1 reference

12 December 2020

Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum(II) with its targets.

1 reference

12 December 2020

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity

1 reference

12 December 2020

Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties

1 reference

12 December 2020

Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen

1 reference

12 December 2020

Clinical pharmacology of high-dose cisplatin by Corden et al.

1 reference

12 December 2020

Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00195372

1 reference

release_wi54chpsmrfutha576xhni3zju

12 September 2017

0 references

PubMed ID

3049431

1 reference

PubMed ID

3049431